Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
23 Jan 2017 | 1:26 AM
 

Sun Pharmaceutical Industries Ltd. Share Price Live (BSE)
0

BSE Code: 524715 | NSE Symbol: SUNPHARMA
640.90
-3.30
(-0.51 %)
20 Jan 2017 | 04:01 PM
Change company
  • Open (Rs)
    644.00
  • Prev. close (Rs.)
    644.21
  • High (Rs.)
    647.46
  • Low (Rs.)
    640.00
  • 52W H (Rs.)
    898.00
  • 52W L (Rs.)
    572.40
  • Volume (Rs.)
    112599
  • MCap (Rs in Cr.)
    1,53,769.22

Upside Rating

Upside Rating denotes four star rating for Sun Pharmaceutical Industries Ltd. on the basis of Earning Revision, Technical, Valuation Trends and Relative performance.
1/4 
Very weak interest since 2017-01-03.
Earnings Revision Trend
Analysts negative since 2017-01-03
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 2017-01-03 at a price of 636.10.

Switch Proposals

This column provides you to switch proposals on alternative stocks against the current non performing stocks in your current holdings.
Company NameUpside RatingRisk
Rating

Risk Rating

Risk Rating denotes the sensitivity of Sun Pharmaceutical Industries Ltd. to extrinsic factors like bad news and fall in stock market. The risk is denoted with low, medium and high ratings.
The stock is classified in the medium-risk zone since 2016-12-02.
Bear Market
Average risk positioning during market declines 
On average, the stock is likely to decline with the index.
Bad News
Slight market sanction in case of specific pressure 
When the stock's pressure is specific, the market sanction on average is 2.72%.
Beta
58
Low sensitivity to SENSEX30 
For 1% of index variation, the stock varies on average by 0.58%.
Correlation
0.3041
Weak correlation to SENSEX30 
Stock movements are strongly independent of index variations.
Value at Risk
78.5
The medium term value at risk is estimated at INR 78.50 or 12.236% 
The value at risk is estimated at INR 78.50. The risk is therefore 12.236. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%%.

Trend Signal & Target Price

The trend is an indicative of the price trend expected in Sun Pharmaceutical Industries Ltd. The target price reflects a combination of fair fundamental price and technical considerations.
Trend Signal
Target Price
563.05

Key Facts

Key Facts aggregates the key company related figures such as PE ratios, dividend yields and 4 week stock performance for Sun Pharmaceutical Industries Ltd.
Mkt Cap in $bn
Large-cap 
With a market capitalization >$5bn, SUN PHARM.INDS.LTD. is considered a large-cap stock.
22.5812
G/PE Ratio
9.785% discount to expected growth 
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of 9.785%.
0.998
LT P/E
Estimated PE for 2019 
The estimated PE is for the year 2019.
16.72
LT Growth
Current year to 2019 annualized estimate 
The annualized growth estimate is for the current year to 2019.
16.044%
Avg. No. of Analysts
Strongly followed by financial analysts 
Over the last seven weeks, an average of 30 analysts provided earnings per share estimates.
30
Dividend Yield
Dividend is largely covered by profits 
The twelve month estimated dividend yield represents 10.641% of earnings forecasts.
0.636%
4 Week Relative Performance
vs. SENSEX30 
The four week relative performance versus SENSEX30 is -0.590%.
-0.59%

Upgrades / Downgrades

Upgrades / Downgrades denotes the history of change in star ratings for Sun Pharmaceutical Industries Ltd.

Star Ratings is a stock selection tool which can help you choose the right stocks based on fundamental, technical and analyst recommendations. Get the complete list of stock trading tips and recommendations here.

Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.